methamphetamine and ibudilast

methamphetamine has been researched along with ibudilast in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (80.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Beardsley, PM; Hendrick, E; Johnson, KW; Shelton, KL1
Adkins, DE; Beardsley, PM; McClay, JL; Snider, SE; van den Oord, EJ; Vunck, SA1
Beardsley, PM; Hendrick, ES; Snider, SE1
Bastola, DR; Bevins, RA; Charntikov, S; Pendyala, G; Pittenger, ST; Thapa, I1
Heinzerling, KG; Roche, DJ; Shoptaw, S; Swanson, A-N; Worley, MJ1
Andrenyak, DM; DeYoung, DZ; Furst, BA; Heinzerling, KG; Moody, DE; Shoptaw, SJ; Swanson, AN; Tsuang, J; Wu, YN; Yi, Y1
Amaya, S; Birath, JB; Briones, M; Furst, B; Heinzerling, K; Maes, L; McKay, C; Obermeit, L; Shoptaw, S; Swanson, AN; Tsuang, J; Wright, MJ1
Amini, K; Tahvilian, R; Zhaleh, H1
Briones, MS; Heinzerling, KG; Kalmin, MM; Li, MJ; Shoptaw, SJ1
Briones, M; Heinzerling, KG; Hinkin, CH; Shoptaw, SJ; Thames, AD; Wu, YN; Zhu, T1

Trials

4 trial(s) available for methamphetamine and ibudilast

ArticleYear
Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.
    Drug and alcohol dependence, 2016, 05-01, Volume: 162

    Topics: Adult; Amphetamine-Related Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Inpatients; Male; Methamphetamine; Middle Aged; Pyridines; Reward; Self Administration; Vasodilator Agents

2016
Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment.
    Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:4

    Topics: Administration, Intravenous; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Methamphetamine; Middle Aged; Outcome Assessment, Health Care; Phosphodiesterase Inhibitors; Pyridines

2016
Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder.
    Drug and alcohol dependence, 2020, 01-01, Volume: 206

    Topics: Adult; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cross-Over Studies; Female; Humans; Inflammation Mediators; Infusions, Intravenous; Male; Methamphetamine; Middle Aged; Phosphodiesterase Inhibitors; Pyridines

2020
Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2020, Volume: 15, Issue:2

    Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Double-Blind Method; Female; Humans; Inflammation Mediators; Male; Methamphetamine; Middle Aged; Phosphodiesterase Inhibitors; Pyridines; Treatment Outcome

2020

Other Studies

6 other study(ies) available for methamphetamine and ibudilast

ArticleYear
The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.
    European journal of pharmacology, 2010, Jul-10, Volume: 637, Issue:1-3

    Topics: Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Methamphetamine; Neuroglia; Phosphodiesterase Inhibitors; Pyridines; Rats; Rats, Long-Evans; Secondary Prevention; Stress, Psychological; Time Factors

2010
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice.
    European journal of pharmacology, 2012, Mar-15, Volume: 679, Issue:1-3

    Topics: Animals; Central Nervous System Sensitization; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Phosphodiesterase Inhibitors; Pyridines

2012
Glial cell modulators attenuate methamphetamine self-administration in the rat.
    European journal of pharmacology, 2013, Feb-15, Volume: 701, Issue:1-3

    Topics: Animals; Behavior, Animal; Male; Methamphetamine; Minocycline; Neuroglia; Pyridines; Rats; Self Administration; Substance-Related Disorders

2013
Ibudilast reverses the decrease in the synaptic signaling protein phosphatidylethanolamine-binding protein 1 (PEBP1) produced by chronic methamphetamine intake in rats.
    Drug and alcohol dependence, 2015, Jul-01, Volume: 152

    Topics: Animals; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; Phosphatidylethanolamine Binding Protein; Prefrontal Cortex; Proteomics; Pyridines; Rats; Reinforcement Schedule; Self Administration; Signal Transduction; Synaptosomes

2015
Ibudilast may improve attention during early abstinence from methamphetamine.
    Drug and alcohol dependence, 2017, 09-01, Volume: 178

    Topics: Amphetamine-Related Disorders; Attention; Humans; Impulsive Behavior; Methamphetamine; Pyridines; Reaction Time

2017
Signal Transduction of Improving Effects of Ibudilast on Methamphetamine Induced Cell Death.
    Asian Pacific journal of cancer prevention : APJCP, 2019, 09-01, Volume: 20, Issue:9

    Topics: Animals; Apoptosis; Bronchodilator Agents; Central Nervous System Stimulants; Drug Combinations; Methamphetamine; Mitochondria; PC12 Cells; Pyridines; Rats; Reactive Oxygen Species; Signal Transduction

2019